PRO-C3 peptides have often been used as a marker of liver fibrosis in patients with PSO treated with methotrexate; however, they were eventually replaced by fibrosis-4 (FIB-4) [36,37]. The gene discussed is C3; the disease is Hepatic fibrosis.